Status: current, Defined. Date: 30-Sep 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3068061000168115 | Naropin 0.2% (ropivacaine hydrochloride 40 mg / 20 mL) injection, 5 x 20 mL ampoules (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3068071000168114 | Naropin 0.2% 40 mg/20 mL injection, 5 x 20 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Naropin 0.2% 40 mg/20 mL injection, 5 x 20 mL ampoules | Is a | Naropin 0.2% (ropivacaine hydrochloride 40 mg / 20 mL) injection, 5 x 20 mL ampoules (trade product pack) | true | Inferred relationship | Some | ||
| Naropin 0.2% 40 mg/20 mL injection, 5 x 20 mL ampoules | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Naropin 0.2% 40 mg/20 mL injection, 5 x 20 mL ampoules | has TPUU | Naropin 0.2% 40 mg/20 mL injection, 20 mL ampoule | true | Inferred relationship | Some | 1 | |
| Naropin 0.2% 40 mg/20 mL injection, 5 x 20 mL ampoules | has container type | ampoule | true | Inferred relationship | Some | ||
| Naropin 0.2% 40 mg/20 mL injection, 5 x 20 mL ampoules | has TP | Naropin 0.2% | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR